Rylance’s Richard III

When it comes to Shakespeare, not all plays are created equal. That’s far from a surprise to anyone who pays attention; Hamlet certainly ranks far ahead of King John in the canon, and even Coriolanus and Timon of Athens get more attention than Pericles. A great deal of this situation in recent years, at least in the U.S., is attributable to the educational curriculum, which has a strong hand in creating the “greatest hits.” The hierarchy is also a product of performers’ aspirations, and I daresay that when asked what Shakespeare roles they’d like to play, actors respond more frequently with Lear and Rosalind than Henry VIII and the Countess of Roussillon.

Rylance in Twelfth Night

The choices for the current Shakespeare plays in repertory on Broadway are among the more familiar titles, but they take on novelty for being all-male casts and indeed for being in rotating rep. Had it not been for the coincidence of a competing rep of Waiting For Godot and No Man’s Land in the same season, the Shakespeares would have been the only shows in rep on Broadway since the mid-90s. A key selling point in the Shakespeare rep is actor Mark Rylance, playing Olivia in Twelfth Night (or Twelfe Night as they’re spelling it in ads) and the title role in King Richard The Third.  After his triumphs in Boeing Boeing, La Bête and Jerusalem, one suspects the audiences would flock to anything Rylance chose to perform, except perhaps those poems he reads as award acceptance speeches.

The January calendar of Twelfth Night and Richard III

So while it’s hardly the discovery of a shocking secret, I was surprised today to discover that the Shakespeare rep doesn’t treat its productions as equals: in general there are six weekly performances of Twelfth Night and only two of Richard III. The producers (and perhaps Mr. Rylance) have decided that the market will bear plenty of comedy and not so much tragedy, with the added bonus that Stephen Fry appears only in the comedy, and for some of us, he’s a big draw too. They also may be saving a few dollars by making fewer set changeovers, since labor costs money.

I can’t say that I wouldn’t have lobbied for the same balance, if I’d had a say in the matter. I happen to have a great love for Twelfth Night, due to it having been the first play I worked on when I started at Hartford Stage in 1985. As for Richard III, even though I’ve seen terrific productions with Ian McKellen and Richard Thomas, among others, I always feel a bit lost in the constant realignment of loyalties throughout the play, and I rarely walk away having had an emotional experience, even as I might appreciate the talent on stage. Indeed, my college roommate, who has been my Shakespeare wingman for some three decades, was befuddled when I refused to see Richard III at BAM last year; I just didn’t feel like it and he wasn’t going to change my mind (he took his mother-in-law). By the way, I should note I have not yet seen the current Broadway shows.

Shakespeare scholars and Rylance buffs may be dismayed to learn of this programming imbalance. The former might not cotton to the elevation of a comedy over a history, but the latter may just be realizing that if they wish to be Rylance completists, they’d better hustle up on getting tickets, because the Richard III inventory is much scarcer than the seats for Twelfth Night.  As for whether there’s a deeper meaning to favoring one play over the other beyond gauging the marketplace, I leave that for the academics to debate.

P.S. Waiting for Godot and No Man’s Land each play four shows a week. Make of that, you should pardon the expression, What You Will.

Macbeth. Twelfth Night. Richard III. Romeo and Juliet. No Man’s Land. Waiting For Godot. Betrayal. The Winslow Boy.

The syllabus for a university survey course in drama? No. Instead, it’s the roster of eight of the 16 titles scheduled to open on Broadway between now and the end of 2013.

To be sure, British plays, artists and productions haven’t ever been strangers to Broadway, but this preponderance of works – featuring actors such as Jude Law, Mark Rylance, Rachel Weisz, Daniel Craig, Anne-Marie Duff, Stephen Fry, Orlando Bloom, Roger Rees, Ian McKellen and Patrick Stewart – in the 40 theatres that comprise Broadway, all at the same time, is an embarrassment of riches. Add in concurrent Off-Broadway productions of A Midsummer Night’s Dream with David Harewood and Kathryn Hunter (opening the new Theatre for a New Audience space in Brooklyn) and Michael Gambon and Eileen Atkins in All That Fall, and it appears that Anglophilia is running rampant in the playhouses of New York.

Much of this is coincidence, since it’s not as if producers conspire on themes. Indeed, from a marketing standpoint, it’s not necessarily even a good idea, since the theatregoers most drawn to this work may have to face some tough buying decisions unless they have unlimited resources and time. Cultural tourists won’t even be able to fit all of these terrific sounding shows in, should they fly to the city for merely a long weekend.

But whether the productions are transfers from the UK or newly minted in America, as is the case with No Man’s Land, Romeo and Juliet, and Betrayal, the British imprimatur seems as if it’s a requirement this year, even if only in part. UK director David Leveaux is staging Romeo and Juliet with a North American cast capped by Bloom. US director Julie Taymor tapped Harewood and Hunter for A Midsummer Night’s Dream, her first project since the highly-publicised and contentious Spiderman: Turn Off The Dark (a tell-all book by her collaborator Glen Berger will be released just as Midsummer performances begin). Even the US classic The Glass Menagerie is being helmed by John Doyle. Only Classic Stage Company’s Romeo and Juliet, with Elizabeth Olsen and TR Knight, is wholly comprised of American artists, though their Romeo is Japan-born.

The English theatre can certainly take pride in this abundance of talent exported to American shores, and I look forward to each and every one of these shows enthusiastically. Indeed, I’ll pass on my annual autumn trip to London since I’ll need only take the subway and not British Airways.

But it does beg the question of whether classical work can succeed on Broadway without a UK connection. Are producers giving up on our best American actors and directors taking on British and Irish pieces without at least some of that heritage in the shows’ DNA? To be sure, not-for-profit companies may lean American overall (LCT’s Macbeth is Ethan Hawke), but has public television conditioned us to desire the “genuine” article? Great American plays appear on British stages frequently, ranging from A View From The Bridge to Fences to Clybourne Park, without the perpetual need to import Americans, let alone the cream of American talent, to make them work. Yet the power of UK casting appears to be such that even multiple Macbeths are deemed economically viable, with Alan Cumming having played virtually all of the roles on Broadway only months ago and Kenneth Branagh due at the Park Avenue Armory in June 2014.

I don’t like calling attention to national divisions when it comes to art, but the fall theatre season in New York simply can’t be overlooked. Despite the luxury of all of the great theatre on tap, the timing sends the message to US actors, theatre students, critics and audiences that when it comes to staging foreign classics, the talent exchange flows more strongly from west to east than in the other direction.

But looking on the bright side, perhaps this means we’ll soon enjoy one more benefit of the English stage, and be able to buy ice cream at the interval.